Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC

Clinical trial NCT03719300 · TERMINATED

Trial details

NCT number: NCT03719300
Sponsor: Anchiano Therapeutics Israel Ltd.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-muscle Invasive Bladder Cancer (NMIBC)

Start date: 2019-03-20
Primary completion: 2019-11-18
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.